Titan Pharmaceuticals Ownership | Who Owns Titan Pharmaceuticals?

Titan Pharmaceuticals Ownership Summary

Titan Pharmaceuticals is owned by 6.70% institutional investors, and 93.30% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.45% of its assets in Titan Pharmaceuticals shares.

TTNP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Titan Pharmaceuticals	6.70%	-	93.30%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2023	22	-8.33%	1,006,758	-4.52%	6	13.60%	4	-55.56%	7	600.00%
Sep 30, 2023	24	4.35%	1,054,414	7.80%	7	16.55%	9	50.00%	1	-66.67%
Jun 30, 2023	23	9.52%	978,143	2.99%	6	16.28%	6	-	3	50.00%
Mar 31, 2023	21	-4.55%	949,785	-1.88%	6	12.18%	6	-53.85%	2	-66.67%
Dec 31, 2022	22	57.14%	967,957	-8.17%	7	13.88%	13	85.71%	6	50.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Institutional Extnd Mkt Idx Tr	4.10K	0.45%	-
Fidelity Extended Market Index	3.21K	0.35%	-182.00
Fidelity Nasdaq Composite Index	963.00	0.11%	-
Fidelity Series Total Market Index	523.00	0.06%	-
NT Ext Equity Mkt Idx Fd - L	293.00	0.03%	-
Northern Trust Extended Eq Market Idx	293.00	0.03%	-
NT Ext Equity Mkt Idx Fd - NL	161.00	0.02%	-
SSgA U.S. Extended Market Index Class I	3.10K	0.02%	-
State St US Extended Mkt Indx NL Cl C	155.00	0.02%	-
NT Ext Equity Mkt Idx Fd - DC - NL - T2	130.00	0.01%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 21, 2023	Lazar David E.	Chief Executive Officer	Sell	$441.65K
Jun 21, 2023	Lazar David E.	Chief Executive Officer	Sell	$441.65K
Jan 25, 2023	Lazar David E.	Chief Executive Officer	Buy	$20.07K
Jan 24, 2023	Lazar David E.	Chief Executive Officer	Buy	$36.22K
Jul 06, 2022	Activist Investing LLC		Buy	$739.01K

Insider Transactions Trends

Date	Buy	Sell
2023 Q4	-	-
2023 Q3	-	-
2023 Q2	-	2
2023 Q1	2	-
2022 Q3	1	-

TTNP Ownership FAQ

Who Owns Titan Pharmaceuticals?

Titan Pharmaceuticals shareholders are primarily institutional investors at 6.70%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Titan Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Titan Pharmaceuticals falls below.

Does Blackrock own Titan Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Titan Pharmaceuticals.

Who is the top mutual fund holder of Titan Pharmaceuticals shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Titan Pharmaceuticals shares, with 0.45% of its total shares outstanding invested in 4.1K Titan Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools